IBS DAYS 2026 – Advancing IBS Research and Patient Care

IBS Days 2026 once again demonstrated their importance as an international forum for scientific exchange on Irritable Bowel Syndrome (IBS). As an endorsed event of the European Society of Neurogastroenterology and Motility (ESNM), we are particularly pleased to have supported this high-level congress as it celebrated its 10th anniversary. We are especially proud of the strong ESNM presence throughout the scientific programme, with many of the speakers and experts being members of our Society and making significant contributions through their scientific expertise.

Under the theme "New insights for a better management of irritable bowel syndrome", → IBS Days 2026 provided an excellent opportunity to review the current state of knowledge on a condition that affects up to 10% of the general population while translating the latest scientific evidence into tangible improvements in patient care.
Among the scientific highlights was the presentation of the new Rome V criteria, which provide an important framework for the diagnosis and management of Irritable Bowel Syndrome and other disorders of gut–brain interaction. In addition, the programme addressed all major aspects of IBS, ranging from the latest insights into pathophysiology to the role of diet, the gut microbiota, intestinal permeability, the enteric nervous system and the immune system, alongside modern diagnostic and therapeutic approaches.

A particular focus was placed on everyday clinical practice. Speakers discussed how to accurately diagnose and effectively manage patients with IBS, particularly those with persistent, treatment-resistant or diagnostically challenging symptoms. The highly anticipated Postgraduate Course provided practical strategies for managing these often complex patients and emphasized the importance of careful differential diagnosis.

Following three days of outstanding scientific exchange, attention is already turning to the future. The next edition of IBS Days is planned for two years from now and will once again bring together the international community to discuss the latest developments in IBS research and clinical management.